BRISBANE, March 5, 2016 – Glennon Capital met with the management of National Veterinary Care Limited (NVL) during the week, following the release of their first results as a listed company.

BRISBANE, February 29, 2016 – Half a year since its ASX debut, National Veterinary Care (ASX: NVL) is performing ahead of expectations to show the market can handle another vet-and-pet player.

BRISBANE, February 29, 2016 – National Veterinary Care’s (NVC) share price jumped almost 3 per cent yesterday after its first-half results put it on track to meet full-year prospectus forecasts.

BRISBANE, October 1, 2015 – National Veterinary Care Limited [ASX:NVL] today completed the acquisition of the Initial Portfolio of veterinary clinics outlined in the prospectus prior to the company listing on the Australian Securities Exchange (ASX).

BRISBANE, August 31, 2015 – National Veterinary Care has appointed experienced Human Resources specialist Alison Sherry to its Board as a Non-Executive Director.

BRISBANE, August 14, 2015 – National Veterinary Care (ASX:NVL) today announced that it had acquired 30 clinics in its initial portfolio ahead of the company’s listing on the Australian Securities Exchange.

BRISBANE, August 6, 2015 – National Veterinary Care today announced that it had completed the acquisition of 16 veterinary clinics as the first tranche of practices to be acquired in its initial portfolio of businesses, prior to the company listing on the ASX on 11 August 2015.

BRISBANE, August 3, 2015 – The Initial Public Offering (IPO) for National Veterinary Care (NVC) today closed well oversubscribed, attracting strong support from institutional investor

BRISBANE, July 9, 2015 – National Veterinary Care (NVC) today lodged a prospectus with the Australian Securities and Investments Commission (ASIC) for an initial public offering (IPO) and listing on the Australian Securities Exchange (ASX). The offer opens on July 17 and closes on July 27, with an anticipated commencement of trading on the ASX of August 5. The amount to be raised under the offer is $30m at $1 per share, with an implied market capitalisation of $50.7m. The offer is fully underwritten by Shaw ICS Advisory Pty Limited and Wilson HTM Corporate Finance Ltd.